1. FDA limits paracetamol strength to reduce overdose potential

   News item 13 January 2013 Pages: 1 - 1

2. Common clozapine ADR may be life-threatening

   News item 13 January 2013 Pages: 2 - 2

3. Romiplostim dosing info considers portal vein thrombosis risk

   News item 13 January 2013 Pages: 2 - 2

4. US stakeholders feel REMS programme needs major overhaul

   Media release 13 January 2013 Pages: 2 - 2

5. Dronedarone linked with severe liver injury

   News item 13 January 2013 Pages: 3 - 3

6. Update on FDA's Mini-Sentinel System

   News item 13 January 2013 Pages: 3 - 3

7. In their January 2011 Drug Safety Update, the UK MHRA warns that treatment with either bevacizumab [Avastin] or sunitinib [Sutent]

   News item 13 January 2013 Pages: 3 - 3

8. A European review has shown that the combination of pioglitazone [Actos] and insulin is associated with an increased risk of heart failure,

   News item 13 January 2013 Pages: 3 - 3

9. Following a review of four published observational studies, the US FDA has issued a statement

   News item 13 January 2013 Pages: 3 - 3

10. All opioids are not created equal, in terms of safety

    News item 13 January 2013 Pages: 4 - 4

11. Prescription drugs and injurious car crashes linked in France

    Clinical study 13 January 2013 Pages: 4 - 4

12. Adalimumab/infliximab

    Case report 13 January 2013 Pages: 5 - 5

13. Adalimumab

    Case report 13 January 2013 Pages: 5 - 5

14. Abatacept

    Case report 13 January 2013 Pages: 5 - 5

15. Adalimumab/infliximab

    Case report 13 January 2013 Pages: 5 - 5

16. Alglucosidase-α

    Case report 13 January 2013 Pages: 6 - 6

17. Ajmaline

    Case report 13 January 2013 Pages: 6 - 6

18. Allopurinol/methylprednisolone

    Case report 13 January 2013 Pages: 6 - 6

19. Alendronic acid

    Case report 13 January 2013 Pages: 6 - 6

20. Alendronic acid

    Case report 13 January 2013 Pages: 6 - 6

21. Amlodipine

    Case report 13 January 2013 Pages: 7 - 7

22. Amphotericin B/methotrexate interaction

    Case report 13 January 2013 Pages: 7 - 7

23. Amphotericin B liposomal

    Case report 13 January 2013 Pages: 7 - 7

24. Antiretrovirals

    Case report 13 January 2013 Pages: 8 - 8

25. Anabolic and androgenic steroids abuse

    Case report 13 January 2013 Pages: 8 - 8

26. Antineoplastics

    Case report 13 January 2013 Pages: 8 - 8

27. Azathioprine

    Case report 13 January 2013 Pages: 9 - 9

28. Aripiprazole

    Case report 13 January 2013 Pages: 9 - 9

29. Azathioprine/infliximab/mercaptopurine

    Case report 13 January 2013 Pages: 9 - 9

30. Apomorphine

    Case report 13 January 2013 Pages: 9 - 9

31. Atenolol/rivastigmine interaction

    Case report 13 January 2013 Pages: 9 - 9

32. BCG

    Case report 13 January 2013 Pages: 10 - 10

33. Azithromycin/clarithromycin

    Case report 13 January 2013 Pages: 10 - 10

34. Azathioprine/prednisone/tacrolimus

    Case report 13 January 2013 Pages: 10 - 10

35. Bleomycin

    Case report 13 January 2013 Pages: 11 - 11

36. Bisoprolol

    Case report 13 January 2013 Pages: 11 - 11

37. Bisacodyl abuse

    Case report 13 January 2013 Pages: 11 - 11

38. BCG

    Case report 13 January 2013 Pages: 11 - 11

39. Captopril

    Case report 13 January 2013 Pages: 12 - 12

40. Calcium gluconate

    Case report 13 January 2013 Pages: 12 - 12

41. Bortezomib

    Case report 13 January 2013 Pages: 12 - 12

42. Bleomycin

    Case report 13 January 2013 Pages: 12 - 12

43. Bortezomib

    Case report 13 January 2013 Pages: 12 - 12

44. Cetuximab

    Case report 13 January 2013 Pages: 13 - 13

45. Carbamazepine

    Case report 13 January 2013 Pages: 13 - 13

46. Carbamazepine/clozapine/lamotrigine/valproic acid

    Case report 13 January 2013 Pages: 13 - 13

47. Carbamazepine

    Case report 13 January 2013 Pages: 13 - 13

48. Cetuximab

    Case report 13 January 2013 Pages: 14 - 14

49. Cetuximab/erlotinib/gefitinib

    Case report 13 January 2013 Pages: 14 - 14

50. Chorionic gonadotropin/menotropin

    Case report 13 January 2013 Pages: 14 - 14